The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm) lead, which ...

A team of researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta utilized an electrophysiological computer model of the heart’s electrical ...

Joshua Lupton, M.D., has no memory of his own cardiac arrest in 2016. He only knows that first responders resuscitated his heart with a shock from a defibrillator, ultimately leading to his complete ...

The study, published in the New England Journal of Medicine on Nov. 24, studied patient outcomes for three methods of defibrillation: standard defibrillation; double sequential external defibrillation ...

Traditional hospital factors -- such as case volume and academic status -- do not appear to predict whether patients with cardiac arrest at that facility are likely to experience delays in receiving ...

January 2, 2008 (Kansas City, MO)-Delays in the time to defibrillation are common in hospitalized patients with cardiac arrest, with more than 30% of patients with cardiac arrest due to ventricular ...

Registry data suggest that one third of the patients who would benefit most are not receiving timely defibrillation. In the U.S., in-hospital cardiac arrest occurs about twice as often as ...

A new observational study suggests the position in which responders initially place the two defibrillator pads on the body may make a significant difference in returning spontaneous blood circulation ...